Despite promising preclinical results and its favorable safety profile, BPC 157 lacks FDA approval, necessitating further clinical trials to validate its therapeutic potential and establish comprehensive safety data
What if there was something that could have a much more dramatic effect on aging at the cellular level, that takes less time and effort, and in many cases is more cost-effective
Rotate across three sites
A recently published review by Seiwerth et al
For more detailed dosage information on each, see the AOD 9604 dosage guide and the semaglutide dosage guide
In women, BPC-157s purported effects on angiogenesis, tissue repair, and inflammation might impact ovarian function, follicle health, endometrial receptivity, and recovery from pelvic injury or surgery